AU537814B2 - Radioactive diagnostic agent - Google Patents

Radioactive diagnostic agent

Info

Publication number
AU537814B2
AU537814B2 AU67935/81A AU6793581A AU537814B2 AU 537814 B2 AU537814 B2 AU 537814B2 AU 67935/81 A AU67935/81 A AU 67935/81A AU 6793581 A AU6793581 A AU 6793581A AU 537814 B2 AU537814 B2 AU 537814B2
Authority
AU
Australia
Prior art keywords
diagnostic agent
radioactive diagnostic
radioactive
agent
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU67935/81A
Other languages
English (en)
Other versions
AU6793581A (en
Inventor
Yoshiro Omomo
Hideo Saji
Hisashi Tanaka
Akira Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of AU6793581A publication Critical patent/AU6793581A/en
Application granted granted Critical
Publication of AU537814B2 publication Critical patent/AU537814B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67935/81A 1980-03-08 1981-02-27 Radioactive diagnostic agent Ceased AU537814B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2947180A JPS56125317A (en) 1980-03-08 1980-03-08 Stable radioactive diagnosticum with radioactive metallic mark
JP2947180 1980-03-08

Publications (2)

Publication Number Publication Date
AU6793581A AU6793581A (en) 1981-09-17
AU537814B2 true AU537814B2 (en) 1984-07-12

Family

ID=12277007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67935/81A Ceased AU537814B2 (en) 1980-03-08 1981-02-27 Radioactive diagnostic agent

Country Status (6)

Country Link
US (1) US4425319A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0035765B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS56125317A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU537814B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1165686A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3167264D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4479930A (en) * 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
US4666697A (en) * 1982-12-08 1987-05-19 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic agent
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4556068A (en) * 1983-08-26 1985-12-03 The United States Of America As Represented By The Department Of Energy In-vivo measurement of lithium in the brain and other organs
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
EP0170031A1 (de) * 1984-07-04 1986-02-05 Gesellschaft zur Förderung der industrieorientierten Forschung an den Schweizerischen Hochschulen und weiteren Institutionen Radioaktives Diagnosemittel zum Nachweisen einer venösen Thrombose
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863964A (en) * 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
AU593611B2 (en) * 1986-02-14 1990-02-15 Nihon Medi-Physics Co., Ltd. High molecular compounds having amino groups, and their utilization
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
WO1989002752A1 (en) * 1987-09-25 1989-04-06 Genentech, Inc. Method of diagnosing blood clots using fibrin-binding proteins
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
JPH06502177A (ja) * 1990-10-16 1994-03-10 バイオメディカル・フロンティアーズ・インコーポレイテッド 磁気共鳴映像用ポリマー−デフェロキサミン−第２鉄付加物
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
JP3051591B2 (ja) * 1993-03-05 2000-06-12 日本メジフィジックス株式会社 タリウム−２０１の容器に対する付着防止剤
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
AU2003299590B8 (en) 2002-12-09 2010-04-08 Abraxis Bioscience, Llc Compositions and methods of delivery of pharmacological agents
CN1925874B (zh) * 2002-12-09 2014-12-17 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
BR0317134A (pt) * 2002-12-09 2005-11-22 American Bioscience Inc Composições e métodos de liberação de agentes farmacológicos
US11197938B1 (en) * 2016-10-19 2021-12-14 Battelle Memorial Institute System and process for production of isotopes and isotope compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5527973A (en) * 1972-05-08 1974-11-07 Solco Basel Ag PROCESS FORTHE MANUFACTURE OF INJECTABLE PREPARATIONS OF Tc99m AND/OR In113m AND APPARATUS FOR CARRYING OUT THE PROCESS
NL7613339A (nl) * 1975-12-01 1977-06-03 Union Carbide Corp Radiodiagnostische middelen.
JPS5283961A (en) * 1976-01-01 1977-07-13 Pharmacia Fine Chemicals Ab Medicine for administrating in blood

Also Published As

Publication number Publication date
EP0035765A2 (en) 1981-09-16
DE3167264D1 (en) 1985-01-03
US4425319A (en) 1984-01-10
CA1165686A (en) 1984-04-17
JPS56125317A (en) 1981-10-01
JPH036124B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-01-29
AU6793581A (en) 1981-09-17
EP0035765A3 (en) 1982-03-17
EP0035765B1 (en) 1984-11-21

Similar Documents

Publication Publication Date Title
AU537814B2 (en) Radioactive diagnostic agent
AU558827B2 (en) Diagnostic device
GB2074727B (en) Immunulogical diagnostic method
JPS56147349A (en) X-ray unit
JPS5789158A (en) Diagnostic system
JPS56121179A (en) Diagnostic device
AU9165482A (en) X-ray contrast agents
AU523295B2 (en) X-ray contrast agent
AU553720B2 (en) Radioactive capsules
AU565287B2 (en) Radioactive diagnostic agent, and non-radioactive carriers therefor
JPS57112848A (en) Raioactive ray diagnostic apparatus
JPS56109557A (en) Antiibacterial agent
GB2116001B (en) Radioactive test body
AU544719B2 (en) Radioactive diagnostic agent and non-radioactive carrier therefor
AU528640B2 (en) Radioactive diagnostic agent and carrier
GB2085696B (en) Data set diagnostic systems
GB2088170B (en) Data set diagnostic system
AU542420B2 (en) Anti-rhinovirus agents
JPS56129238A (en) Thickening agent
JPS5772049A (en) Tomograph
JPS5774644A (en) Radiographer
JPS5769850A (en) Diagnostic device
JPS5764047A (en) Radiation tomographing diagnostic device
JPS574570A (en) Alpha ray monitoring
AU512203B2 (en) Radioactive diagnostic agent